MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir ® FlexTouch ®, a disposable prefilled insulin pen containing Levemir ® (insulin detemir).
The Food and Drug Administration has approved Novo Nordisk’s prefilled insulin pens called the NovoLog ® FlexTouch ® and Levemir ® FlexTouch ®. FlexTouch ® pens’ dosing mechanism ensures the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback